Amerigo Scientific Strengthens Healthcare Innovation with Comprehensive Portfolio of Biomedical Polymers

Amerigo Scientific reinforced its commitment to advancing the biomedical field by offering biomedical polymers tailored ...
PharmiWeb

Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once ...

Olanzapine long-acting injectable suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation 1If approved, TEV-'749 could help address a ...

Teva Pharmaceutical Industries Ltd: U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV ...

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If approved, TEV-'749 could help address ...
Plastics Technology

March 2026: Prices Up for PE, PP, PS, PVC; PET Flat

Upward trajectory in January for four of the five major commodity resins, but overall processors face less volatility.
Polymerupdate

Polypropylene copolymer prices edge higher in Turkey this week

We use cookies to authenticate, authorize, verify, analyze and secure the application. The application will not work with cookies disabled. if the cookies are disabled on your browser, please enable ...

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly ...

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If approved, TEV-'749 could help address ...